A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors

This study is currently recruiting participants.
Verified November 2012 by Cellceutix Pharmaceuticals
Sponsor:
Information provided by (Responsible Party):
Cellceutix Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01664000
First received: August 2, 2012
Last updated: November 6, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)